As the closely watched screening test moves closer to Food and Drug Administration approval, MedTech Dive asked cancer ...

With Twiist already available in Type 1 diabetes, Sequel has made the automated insulin delivery system available for the Type 2 population.

Edwards is asking customers to return some of the delivery systems used with its Sapien M3 devices after receiving three ...

Stryker, which has been looking to get into the soft tissue robotics market for years, is now positioned to compete with new ...

In a strategy shift, the company will invest in its procedural ultrasound business, supporting cardiovascular surgeries ...

Xodus’ portfolio “complements and expands Steris’ offering, particularly by adding consumables used in the operating room,” ...

The payments were made after a California arbitrator found private text messages between Orthofix executives couldn’t be ...

For the second straight quarter, the cardiovascular unit experienced slower sales growth due to ongoing struggles in the ...

AdvaMed called for more breakthrough devices, including diagnostics, to be eligible for the pathway, and for set timelines ...

MiniMed completed its separation from Medtronic, the companies said Thursday. The diabetes technology firm, which went public ...

BD said Tuesday it has struck a partnership with the Trump administration to expand domestic manufacturing and strengthen the ...

Chief commercial officer, EndoQuest Robotics. Previous title: Vice president of robotics, AI and neuroscience, HCA Healthcare ...